Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

84.18 -1.18 (-1.38%)
Official Closing Price Updated: 4:10 PM EST, Dec 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 75,027
Open 85.05
Bid (Size) 83.06 (3,000)
Ask (Size) 84.81 (2,900)
Prev. Close 85.36
Today's Range 84.18 - 85.40
52wk Range 58.97 - 86.17
Shares Outstanding 82,000
Dividend Yield 1.48%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
The report states that the agreement between the U.S. and the U.K. is expected to be announced in the coming days. 
Via Stocktwits
Topics World Trade
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize. 
Via Benzinga
Topics ETFs

Performance

YTD
+28.3%
+28.3%
1 Month
+10.8%
+10.8%
3 Month
+18.0%
+18.0%
6 Month
+28.7%
+28.7%
1 Year
+21.5%
+21.5%

More News

Read More
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Via Benzinga
News headline image
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗
Via Benzinga
Topics ETFs
White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report ↗
Via Stocktwits
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
Via Benzinga
Topics ETFs
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
Via Benzinga
News headline image
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗
Via Benzinga
News headline image
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' ↗
Via Benzinga
News headline image
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills ↗
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗
Via Benzinga
Topics Government World Trade
News headline image
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗
Via Stocktwits
Topics Government
News headline image
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗
Via Benzinga
News headline image
FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗
Via Stocktwits
News headline image
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading ↗
Via Benzinga
News headline image
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion ↗
Via Benzinga
Topics Government
News headline image
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' ↗
Via Benzinga
Topics Government
News headline image
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks ↗
Via Benzinga
Topics ETFs Government
News headline image
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report ↗
Via Stocktwits
Topics Government Intellectual Property Lawsuit
News headline image
Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗
Via Benzinga
Topics Government
News headline image
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot ↗
Via Benzinga
Topics ETFs
News headline image
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗
Via Benzinga
Topics Government World Trade
News headline image
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On? ↗
Via Benzinga
Topics World Trade

Frequently Asked Questions

Is iShares U.S. Pharmaceutical ETF publicly traded?
Yes, iShares U.S. Pharmaceutical ETF is publicly traded.
What exchange does iShares U.S. Pharmaceutical ETF trade on?
iShares U.S. Pharmaceutical ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares U.S. Pharmaceutical ETF?
The ticker symbol for iShares U.S. Pharmaceutical ETF is IHE on the New York Stock Exchange
What is the current price of iShares U.S. Pharmaceutical ETF?
The current price of iShares U.S. Pharmaceutical ETF is 84.18
When was iShares U.S. Pharmaceutical ETF last traded?
The last trade of iShares U.S. Pharmaceutical ETF was at 12/01/25 04:10 PM ET
What is the market capitalization of iShares U.S. Pharmaceutical ETF?
The market capitalization of iShares U.S. Pharmaceutical ETF is 6.90M
How many shares of iShares U.S. Pharmaceutical ETF are outstanding?
iShares U.S. Pharmaceutical ETF has 7M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.